acetoacetic acid has been researched along with Elevated Cholesterol in 3 studies
acetoacetic acid : A 3-oxo monocarboxylic acid that is butyric acid bearing a 3-oxo substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In order to study the effect of HMG-CoA reductase inhibitor (pravastatin) on ketone formation, changes in the plasma levels of ketone bodies by treatment with pravastatin were studied in 18 non-insulin dependent diabetics with hypercholesterolemia." | 7.70 | Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia. ( Chiba, T; Fukuda, M; Nagakubo, H; Ogawa, S; Oouchi, M; Sato, C; Sato, T; Sugimura, K, 1998) |
| " In order to study the effect of HMG-CoA reductase inhibitor (pravastatin) on ketone formation, changes in the plasma levels of ketone bodies by treatment with pravastatin were studied in 18 non-insulin dependent diabetics with hypercholesterolemia." | 3.70 | Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia. ( Chiba, T; Fukuda, M; Nagakubo, H; Ogawa, S; Oouchi, M; Sato, C; Sato, T; Sugimura, K, 1998) |
| "Unified Parkinson's Disease Rating Scale scores improved in all five during hyperketonemia, but a placebo effect was not ruled out." | 2.71 | Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. ( Boyar, K; Di Rocco, A; Heymsfield, SB; Hyams, K; Nonas, C; Vanitallie, TB, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ulven, SM | 1 |
| Christensen, JJ | 1 |
| Nygård, O | 1 |
| Svardal, A | 1 |
| Leder, L | 1 |
| Ottestad, I | 1 |
| Lysne, V | 1 |
| Laupsa-Borge, J | 1 |
| Ueland, PM | 1 |
| Midttun, Ø | 1 |
| Meyer, K | 1 |
| McCann, A | 1 |
| Andersen, LF | 1 |
| Holven, KB | 1 |
| Vanitallie, TB | 1 |
| Nonas, C | 1 |
| Di Rocco, A | 1 |
| Boyar, K | 1 |
| Hyams, K | 1 |
| Heymsfield, SB | 1 |
| Sato, T | 1 |
| Oouchi, M | 1 |
| Nagakubo, H | 1 |
| Chiba, T | 1 |
| Ogawa, S | 1 |
| Sato, C | 1 |
| Sugimura, K | 1 |
| Fukuda, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT01679496] | 180 participants (Actual) | Interventional | 2012-06-30 | Completed | |||
| Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome[NCT05469997] | 50 participants (Anticipated) | Interventional | 2023-01-31 | Not yet recruiting | |||
| Effect of a Lipidic and Proteic Controlled Diet on Resting Energy Expenditure, Body Composition and Symptoms in Patients With Parkinson's Disease[NCT02687698] | 36 participants (Anticipated) | Interventional | 2016-02-29 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for acetoacetic acid and Elevated Cholesterol
| Article | Year |
|---|---|
Using metabolic profiling and gene expression analyses to explore molecular effects of replacing saturated fat with polyunsaturated fat-a randomized controlled dietary intervention study.
Topics: Acetic Acid; Acetoacetates; Amino Acids; Bile Acids and Salts; Cholesterol, LDL; Diet; Dietary Fats; | 2019 |
Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Antiparkinson Agents; Cholesterol; Combined Modality The | 2005 |
Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Antiparkinson Agents; Cholesterol; Combined Modality The | 2005 |
Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Antiparkinson Agents; Cholesterol; Combined Modality The | 2005 |
Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Antiparkinson Agents; Cholesterol; Combined Modality The | 2005 |
1 other study available for acetoacetic acid and Elevated Cholesterol
| Article | Year |
|---|---|
Effect of pravastatin on plasma ketone bodies in diabetics with hypercholesterolemia.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Aged, 80 and over; Body Mass Index; Cholesterol; Diabete | 1998 |